Northway Biotech

The Northway group of companies unites 17 enterprises operating for more than 20 years in the fields of medicine, biotechnology, biopharmaceuticals, wellness, and investment. The biotechnology cluster, operating under the "Northway Biotech" brand, comprises 7 companies: five in Lithuania, one in the United Kingdom, and one in the USA. In the latter market, "Northway Biotech" is the largest biotechnology investor from the Baltic region.

The biotechnology companies employ a total of more than 200 highly qualified specialists. The companies provide services to international pharmaceutical and biotechnology corporations, including companies publicly listed on European and US stock exchanges. The primary export markets are Europe, North America, and Asia. The group's scientists also collaborate with international scientific institutions to develop innovative biotechnology projects.

Northway Biotech is a member of the Lithuanian consortium for cooperation with the Massachusetts Institute of Technology (MIT), thereby strengthening long-term scientific and industrial collaboration between Lithuania and the US in the life sciences sector. For its leadership in the field of biological drug development and manufacturing, the company was honored with the Outsourced Pharma 2025 CDMO Leadership Awards in the global biologics CDMO category.